Skip to main content
Caplight Logo









Depencare

Depencare

Private
MadridHealthcare & Life Scienceshttps://www.depencare.com/

Last Round

Strategic

Oct 21, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Depencare operates in Healthcare & Life Sciences and is based in Madrid. Its latest recorded funding round was a Strategic round in October 2025.

Depencare is a healthcare company that provides an end-to-end home care platform for elderly and dependent individuals.

Sector

Healthcare & Life Sciences

Verticals

Home & Lifestyle, Telemedicine

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Depencare Comparables

Compare Depencare with similar companies based on industry and business-model similarity.

Depencare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wayalia
91%
Aiudo
90%
Cuideo
89%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Depencare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicOct 21, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

David Gonzalez Prieto

CEO & Co-Founder

Founding Team

Guillermo Domingo

COO

Executive Team

For institutional investors. Book with your work email.

Depencare Investors

Notable investors and investment history

Depencare investors
InvestorRounds
ND VentureSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 213% MoM, reaching 8.7K.

  • Nov 7, 2025

    Monthly visitors grew 81% MoM, from 4.1K to 7.5K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Depencare Filings

Explore SEC and related filing metadata, where available.

Depencare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Depencare's valuation, stock price, and market status.

Is Depencare a public or private company?

Depencare is a private company.

What is the current stock price of Depencare?

Depencare is a private company, so its shares have no public market price. Caplight tracks Depencare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Depencare worth (valuation)?

Valuation information for Depencare is not publicly available.

Can I buy Depencare stock?

Depencare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Depencare's last funding round?

Depencare's most recent funding round was Strategic on October 21, 2025.

Who are the main investors in Depencare?

Key investors in Depencare include ND Venture.

Will Depencare IPO soon?

No public IPO plans have been announced for Depencare.

How can I track Depencare secondary market activity?

Caplight tracks bids, offers, and trades in Depencare's shares on secondary markets.

Firmographic Details

HeadquartersMadrid
Employee Range12
Year Founded2017
Last FundingOct 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?